Mild fibrosis (F0-2) | Severe fibrosis (F3-6) | P value | |
---|---|---|---|
n = 70 | n = 32 | ||
Gender—malea | 33 (47.1) | 20 (62.5) | ns |
Age (years)a | 45.6 ± 13.7 | 50.28 ± 11.25 | ns |
Hbe Ag positivea | 16 | 6 | ns |
Anti Hbe Ab positivea | 54 | 26 | |
HBV DNA (log IU/mL)b | 7.4 ± 4.3 | 7.0 ± 2.5 | ns |
Serum ALT (IU/L)b | 70.5 ± 48.0 | 83.0 ± 59.87 | ns |
Serum AST (IU/L)b | 45.1 ± 22.5 | 64.28 ± 47.3 | ns |
White blood cell count (×109/L)b | 6.4 ± 1.5 | 6.3 ± 1.7 | ns |
Platelet count (×109/L)b | 207.7 ± 45.6 | 196.5 ± 42.8 | ns |
Haemoglobin (g/L)b | 14.0 ± 1.7 | 14.5 ± 1.3 | ns |
Albumin (g/L)b,c | 4.4 ± 0.3 | 4.4 ± 0.3 | ns |
Prothrombin time (s)b,c | 11.4 ± 1.6 | 11.5 ± 2.5 | ns |
Conjugated bilirubin (mg/dL)b,c | 0.19 ± 0.18 | 0.26 ± 0.25 | ns |
Modified histologic activity indexa | |||
0–4 | 47 (67.1) | 1 (3.1) | – |
5–9 | 22 (31.4) | 25 (78.1) | – |
10–14 | 1 (1.4) | 5 (15.6) | – |
15–18 | – | 1 (3.1) | – |
Fibrosisa | – | ||
0 | 33 (47.1) | – | – |
1 | 20 (28.5) | – | – |
2 | 17 (24.2) | – | – |
3 | – | 20 (62.5) | – |
4 | – | 5 (15.6) | – |
5 | – | 5 (15.6) | – |
6 | – | 2 (6.2) | – |